CCS
CE icon

Crosspoint Capital Strategies’s Celanese CE Stock Holding History

Crosspoint Capital Strategies’s Portfolio CE Stock Details CE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16
Closed -$1K – 1023
2015
Q3 		$1K Buy
+16
New +$1.01K ﹤0.01% 664

Other funds holding CE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Crosspoint Capital Strategies's CE Position: Q4 2015 in Review

Crosspoint Capital Strategies sold out of Celanese (CE) in Q4 2015, closing a stake of 16 shares — an estimated $1K sold.

Crosspoint Capital Strategies first reported a position in CE in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 367 funds tracked by Wall St. Rank hold CE as of Q4 2015.

  • Crosspoint Capital Strategies reported no remaining Celanese position as of Q4 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 16 Celanese shares in Q4 2015, an estimated $1K.
  • Crosspoint Capital Strategies first reported a position in Celanese in Q3 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Celanese position peaked at $1K in Q3 2015.
  • 367 funds tracked by Wall St. Rank held Celanese as of Q4 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.